Emmaus Life Sciences (EMMA) EBITDA Margin (2010 - 2026)
Emmaus Life Sciences (EMMA) recorded EBITDA Margin of 60.22% in Q2 2026, up 73.22 percentage points from -12.99% a year earlier and up 100.99 percentage points from the prior quarter.
Powered by 
Analysis
Emmaus Life Sciences (EMMA) EBITDA Margin (2010 - 2026) Analysis & Trends
On a TTM basis, Emmaus Life Sciences' EBITDA Margin came in at 29.67% as of Jun 30, 2026, up 37.30 percentage points year-over-year; for FY2025, it came in at 2.17%, up 13.41 percentage points from FY2024.
- Annual EBITDA Margin has a five-year change of +2.05 percentage points (FY2020 to FY2025).
- Across earlier years, EBITDA Margin came in at -11.24% in FY2024 (-23.31 pp), 12.07% in FY2023 (+47.59 pp), -35.52% in FY2022 (-6.08 pp) and -29.45% in FY2021 (-29.57 pp).
- The Q2 2026 figure is the highest quarterly EBITDA Margin in data going back to Q4 2010.
- On a year-over-year basis, EBITDA Margin rose in five of the last eight quarters, with an average year-over-year change of +17.77 percentage points.
- Peak year-over-year performance for EBITDA Margin in the last five years was a gain of 140.21 percentage points in Q4 2022, against a drop of 169.92 percentage points in Q4 2021 at the low end.
- Per Business Quant, the preceding three quarters came in at -40.77% (Q1 2026), 23.39% (Q4 2025) and 21.02% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,171.37 Bn | 1,139.96 Bn | 19.71 Bn | 53.49% |
| 2 | Johnson & Johnson | 645.23 Bn | 565.09 Bn | 17.30 Bn | 32.68% |
| 3 | AbbVie | 502.25 Bn | 475.37 Bn | 12.70 Bn | 49.01% |
| 4 | Merck | 361.34 Bn | 315.71 Bn | 12.21 Bn | 6.02% |
| 5 | Novartis Ag | 302.82 Bn | 266.81 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 267.91 Bn | 241.60 Bn | 12.86 Bn | 33.11% |
| 7 | Amgen | 242.39 Bn | 197.79 Bn | 7.24 Bn | 46.01% |
| 8 | Gilead Sciences | 193.55 Bn | 167.74 Bn | 6.22 Bn | -124.26% |
| 9 | Pfizer | 172.05 Bn | 118.70 Bn | 10.94 Bn | 39.16% |
| 10 | Emmaus Life Sciences | 4.21 Mn | -2.09 Mn | 5.97 Mn | 62.03% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 62.03% |
| Mar 31, 2026 | -32.49% |
| Dec 31, 2025 | 28.35% |
| Sep 30, 2025 | 25.22% |
| Jun 30, 2025 | -8.45% |
| Mar 31, 2025 | -36.41% |
| Dec 31, 2024 | -14.46% |
| Sep 30, 2024 | 16.34% |
| Jun 30, 2024 | 12.22% |
| Mar 31, 2024 | -89.39% |
| Dec 31, 2023 | 29.43% |
| Sep 30, 2023 | 12.26% |
| Jun 30, 2023 | 37.35% |
| Mar 31, 2023 | -8.50% |
| Dec 31, 2022 | -15.06% |
| Sep 30, 2022 | -2.33% |
| Jun 30, 2022 | -24.91% |
| Mar 31, 2022 | -81.69% |
| Dec 31, 2021 | -150.66% |
| Sep 30, 2021 | 6.33% |
API Access
Emmaus Life Sciences EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=EMMA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "EMMA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=EMMA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();